An investigator-blind, randomized, 4-week, parallel-group, multicenter pilot study to compare the safety and efficacy of a nonsteroidal cream (Promiseb Topical Cream) and desonide cream 0.05% in the twice-daily treatment of mild to moderate seborrheic dermatitis of the face

Bikowski, 2009, Facial seborrheic dermatitis: a report on current status and therapeutic horizons, J Drugs Dermatol, 8, 125 DeAngelis, 2005, Three etiologic facets of dandruff and seborrheic dermatitis: Malassezia fungi, sebaceous lipids, and individual sensitivity, J Investig Dermatol Symp Proc, 10, 295, 10.1111/j.1087-0024.2005.10119.x Mayo Clinic Web site Barnes, 1998, Anti-inflammatory actions of glucocorticoids: molecular mechanisms, Clin Sci (Lond), 94, 557, 10.1042/cs0940557 Naldi, 2009, Clinical practice. Seborrheic dermatitis, N Engl J Med, 360, 387, 10.1056/NEJMcp0806464 McGinley, 1975, Quantitative microbiology of the scalp in non-dandruff, dandruff, and seborrheic dermatitis, J Invest Dermatol, 64, 401, 10.1111/1523-1747.ep12512335 Bergbrant, 1991, Seborrheic dermatitis and Pityrosporum ovale: cultural, immunological and clinical studies, Acta Derm Venereol Suppl (Stockh), 167, 1 Dawson, 2007, Malassezia globosa and restricta: breakthrough understanding of the etiology and treatment of dandruff and seborrheic dermatitis through whole-genome analysis, J Investig Dermatol Symp Proc, 12, 15, 10.1038/sj.jidsymp.5650049 Gupta, 2004, Prescribing practices for seborrheic dermatitis vary with the physician's specialty: implications for clinical practice, J Dermatolog Treat, 15, 208, 10.1080/09546630410032430 Kircik, 2009, An open-label, single-center pilot study to determine the antifungal activity of a new nonsteroidal cream (Promiseb Topical Cream) after 7 days of use in normal volunteers, Clin Dermatol, 27, S44, 10.1016/j.clindermatol.2009.09.004 Nalamothu, 2009, Evaluation of a nonsteroidal topical cream in a guinea pig model of Malassezia furfur infection, Clin Dermatol, 27, S41, 10.1016/j.clindermatol.2009.09.003 Veraldi, 2008, Treatment of mild to moderate seborrhoeic dermatitis with MAS064D (Sebclair), a novel topical medical device: results of a pilot, randomized, double-blind, controlled trial, J Eur Acad Dermatol Venereol, 22, 290, 10.1111/j.1468-3083.2007.02404.x 2009 Koo, 1999, Duration of remission of psoriasis therapies, J Am Acad Dermatol, 41, 51, 10.1016/S0190-9622(99)70406-8